| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a4b70c9eaaf7b7b504b935cc18c39ec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6937
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G81-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate |
2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef7a46388d61ade86f42e20af298e2cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_506e1ef3b9dc8f4c42d097454299a351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7450f3a71100f7f7bf1e30ede2b7c6b8 |
| publicationDate |
2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021088603-A |
| titleOfInvention |
Polymer nanoparticles |
| abstract |
PROBLEM TO BE SOLVED: To provide polymer nanoparticles. The present invention is a method for treating a specific disease with polymer nanoparticles containing a pharmaceutical combination, a pharmaceutical composition containing the same, and the need for these polymer nanoparticles. With respect to methods including administration to a subject. The above-mentioned free translation composition is a) polymer nanoparticles containing poly (lactic acid) -poly (ethylene glycol) -poly (propylene glycol) -poly (ethylene glycol) (PLA-PEG-PPG-PEG) tetrablock copolymer; b). One or more chemotherapeutic or anticancer targeting agents; and c) peptides containing NuBCP-9 (SEQ ID NO: 1) or peptides containing MUC1 (SEQ ID NO: 2) may be included. [Selection diagram] None |
| priorityDate |
2015-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |